Vancouver, British Columbia
(FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF)
(the “Company”) is pleased to announce that it has been granted a
Final Order from the Supreme Court of BC for the Plan of
Arrangement as approved 100%, at the recent shareholders’
meeting.
The record date for the first
subsidiary company holding the TULIP(TM) Intellectual Property to
be spun out is Tuesday, March 20, 2017. Details and the final share
conversion factor for this subsidiary will be announced upon the
push out of the new shares to shareholders.
For the Cannabis Farm of 50 Hectares and CBD Plant Oils
Extraction firm being purchased by the C&C Cosmeceuticals,
Nutraceuticals and Bio-Chemicals subsidiary, the company is working
with their recently appointed broker/dealer to finalize all
remaining details. The record date for shareholders of the
company to receive shares on a 1 for 1 basis for this subsidiary
shall be announced shortly.
For Further Information, Contact: Ron Ozols, Director
EVITRADE Health Systems
Corporation
(formerly Auxellence Health
Corporation)
Twitter: @evitradehealth or
https://twitter.com/evitradehealth
Email: info@auxellence.com
Website: http://www.auxellence.com
CSE Micro-site:
http://thecse.com/en/listings/technology/evitrade-health-systems-corp
US OTC Markets:
http://www.otcmarkets.com/stock/AXHLF/news
About EVITRADE Health (CSE: EVA, OTCQB:
AXHLF)
EVITRADE (formerly Auxellence
Health Corp.), was founded in 2013 to provide online “digital
healthcare” services for resolving common health problems. The
current markets are weight-loss, high blood pressure, high blood
glucose and heart arrhythmia.
About TULIP™
The TULIP™ system is an online
self-service intended for adults interested in normalizing blood
pressure, heart rate and rhythm, blood glucose, and body weight.
Measurement procedures, conditioning protocols, and session
schedules are prescribed automatically from data acquired by the
user’s TULIP™ device – a blood pressure monitor with interactive
protocols that can feed medical records and expert systems useful
in testing, tracking and treating common health conditions.
The Tulip™ medical device has
received Health Canada and CE Mark certifications.
About C&C
Cosmeceuticals Corp. (“C&C” a wholly owned subsidiary of the
Company)
C&C was founded in 2011 to
develop, manufacture and market nutraceutical and cosmeceutical
personal healthcare products and services. It was the
predecessor company that acquired Auxellence Health Corporation,
which is now named EVITRADE Health Systems Corp. and is a wholly
owned subsidiary. On November 15, 2016, the company announced that
it signed an MOU to acquire a 50 Hectare Cannabis Farm for C&C
and on January 23, 2017 the company that it signed a LOI to acquire
a Plant Oils Extraction firm for C&C. On March 3, 2017 at
the shareholders meeting, C&C was voted 100% in favour of to be
spun off from the parent company and it was announced on March 6,
2017 that C&C was to be spun off on a 1:1 basis. All
shareholders holding shares in EVITRADE will receive shares an
equal number of shares in C&C as of the record date, which
shall be announced shortly.
Disclaimers – Forward Looking Statements
